https://www.indianpharmapost.com/dr-lal-path-labs-posts-q4-fy23-consolidated-pat-at-rs-567-cr-141252023-05-13T00:00:00+05:30always0.9https://www.indianpharmapost.com/alembic-q4-fy23-consolidated-pat-up-at-rs-4825-cr-141262023-05-13T00:00:00+05:30always0.9https://www.indianpharmapost.com/cipla-reports-q4-fy-23-consolidated-pat-at-rs-52565-cr-141272023-05-13T00:00:00+05:30always0.9https://www.indianpharmapost.com/usfda-approves-astellas-veozah-for-treatment-of-vasomotor-symptoms-due-to-menopause-141282023-05-13T00:00:00+05:30always0.9https://www.indianpharmapost.com/nippon-express-italia-receives-iata-ceiv-pharma-certification-for-its-facility-near-milan-malpensa-airport-141292023-05-13T00:00:00+05:30always0.9